Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 8Brain Neoplasms 8Breast Neoplasms 4Urinary Bladder Neoplasms 3Thyroid Neoplasms 3Ovarian Neoplasms 3Neuroendocrine Tumors 3Neoplasm Metastasis 3Glioma 3Cholangiocarcinoma 3Carcinoma, Hepatocellular 3Uterine Cervical Neoplasms 2Testicular Neoplasms 2Stomach Neoplasms 2Spinal Cord Neoplasms 2Small Cell Lung Carcinoma 2Sarcoma 2Salivary Gland Neoplasms 2Prostatic Neoplasms 2Pheochromocytoma 2Paraganglioma 2Pancreatic Neoplasms 2Neoplasms 2Meningioma 2Lung Neoplasms 2Gliosarcoma 2Carcinoma, Transitional Cell 2Astrocytoma 2Adrenal Gland Neoplasms 2Vaginal Neoplasms 1

Interventions

Temozolomide 23Bevacizumab 18Cyclophosphamide 9Carboplatin 7Lomustine 6Irinotecan 63-Iodobenzylguanidine 6Topotecan 5Radiotherapy 5Filgrastim 5Radiosurgery 4Nivolumab 4Everolimus 4Etoposide 4Drug Therapy 4Busulfan 4sonidegib 3pembrolizumab 3olaparib 3fludarabine phosphate 3fludarabine 3cemiplimab 3antineoplaston AS 2-1 3antineoplaston A10 3Vincristine 3Thiotepa 3Sirolimus 3Melphalan 3IL13-PE38 3Antilymphocyte Serum 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recurrence × Fluorodeoxyglucose F18 × CNS × Clear all
NCT04315584 2020-03-24

FDG and FDOPA PET Demonstration of Functional Brain Abnormalities

University of Virginia

Phase EARLY_PHASE1 Unknown
5 enrolled
CNS

Glioblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡